Quetiapine fumarate (Seroquel)

DRUG4 trials

Sponsors

AstraZeneca

Conditions

Bipolar DepressionBipolar DisorderDepressionMajor Depressive DisorderSchizophrenia

Phase 2

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder

CompletedNCT00733668

AstraZenecaMajor Depressive Disorder

Start: 2006-03-31End: 2007-11-30Updated: 2009-03-25

Phase 3

Seroquel in Bipolar Depression Versus SSRI

CompletedNCT00119652

AstraZenecaBipolar Depression, Bipolar Disorder, Depression

Start: 2005-05-31End: 2007-05-31Updated: 2013-01-04

Seroquel XR in Adults With Schizophrenia

TerminatedNCT00852631

AstraZenecaSchizophrenia

Start: 2009-02-28End: 2010-05-31Updated: 2012-07-17

Phase 4

Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic

CompletedNCT00428350

AstraZenecaSchizophrenia

Start: 2006-12-31End: 2007-09-30Target: 120Updated: 2009-03-25

Related Papers

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

2010-01-26189 citations